Last update 01 Apr 2025

Advanced Viral Research Corp.

Private Company|
1985|
New York, United States
|
50-100
| OTC: ADVR|
www.adviral.com

Overview

Tags

Other Diseases
Recombinant polypeptide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Immune System Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Recombinant polypeptide1

Related

1
Drugs associated with Advanced Viral Research Corp.
AVR-118
Target-
Mechanism
Immunomodulators
Active Org.
EOM Pharmaceuticals Holdings, Inc. [+2]
Originator Org.
Advanced Viral Research Corp.
Active Indication
Acquired Immunodeficiency Syndrome [+4]
Inactive Indication
Advanced cancer [+7]
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Advanced Viral Research Corp.
NCT00127517
/ TerminatedPhase 2
A Phase II Double Blind, Placebo Controlled, Randomized, > Multicenter Study With AVR118 Solution in Patients With Advanced > Malignancies Who Are Not Candidates for Curative Chemotherapy.
100 Clinical Results associated with Advanced Viral Research Corp.
Login to view more data
0 Patents (Medical) associated with Advanced Viral Research Corp.
Login to view more data
100 Deals associated with Advanced Viral Research Corp.
Login to view more data
100 Translational Medicine associated with Advanced Viral Research Corp.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
2
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
AVR-118
Hematologic Neoplasms
More
Discontinued
AVR-147
 ( Proteasome )		Neoplasms
More
Pending
AVR-168
 ( KIF11 )		Neoplasms
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free